Pharmaco - Press Releases

Date	Title	Company
06-Sep-2021	Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)	Newron
06-Sep-2021	Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)	Newron Pharmaceuticals SpA
06-Sep-2021	Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)	Newron Pharmaceuticals S.p.A.
06-Sep-2021	After a successful winter initiative, CytoSMART Research Grant project resumes again	CytoSMART Technologies
06-Sep-2021	BIMZELX®▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide	UCB
06-Sep-2021	New MicroCNX Connectors a First for Small-Volume Biopharma Processing Only alternative to tube welding at small tubing sizes	CPC Biopharma
06-Sep-2021	Cannovum AG starts European cannabis expansion with founding of Cannovum Iberia LDA	Cannovum AG
06-Sep-2021	Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia	Newron Pharmaceuticals SpA
06-Sep-2021	Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia	Newron Pharmaceuticals S.p.A.
03-Sep-2021	Element strengthens North American Life Sciences business with acquisition of Impact Analytical	Element Materials Technology
03-Sep-2021	Empagliflozin (Jardiance®) receives MHRA approval for the treatment of heart failure with reduced ejection fraction	Boehringer Ingelheim
03-Sep-2021	Novartis presents new findings at ERS reinforcing the efficacy of Enerzair® Breezhaler®, highlighting its digital companion, as well as showcasing commitment to low	Novartis
03-Sep-2021	Tiziana Life Sciences plc Posting of Scheme Document and Notice of Meetings	Tiziana Life Sciences
03-Sep-2021	NICE recommends Novartis Cosentyx® (secukinumab) for children and young people with moderate to severe psoriasis	Novartis
03-Sep-2021	Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing	Thermo Fisher Scientific
03-Sep-2021	Evotec and Secarna Pharmaceuticals expand strategic partnership in the field of antisense drug discovery	Evotec and Secarna Pharmaceuticals
03-Sep-2021	Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration	Evotec
03-Sep-2021	Government subsidises medicine to combat high cholesterol in ‘high-risk’ Australians	Sanofi
03-Sep-2021	Novartis presents new findings at ERS reinforcing the efficacy of Enerzair® Breezhaler®, highlighting its digital companion, as well as showcasing commitment to low carbon footprint asthma solutions	Novartis
03-Sep-2021	Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential	BRAIN Biotech AG